Ascorbate protects human kidney organoids from damage induced by cell-free hemoglobin
Disease Models & Mechanisms · 01.12.2023 · 16 (12)
DOI: 10.1242/dmm.050342 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 01.12.2023. Verfasst von Julie Bejoy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN 37232, USA. Hauptthemen laut MEDLINE: Sepsis, Acute Kidney Injury. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NEI NIH HHS, NIEHS NIH HHS.
Abstract (Originalsprache)
Sepsis-associated acute kidney injury is associated with high morbidity and mortality in critically ill patients. Cell-free hemoglobin (CFH) is released into the circulation of patients with severe sepsis and the levels of CFH are independently associated with mortality. CFH treatment increased cytotoxicity in the human tubular epithelial cell line HK-2. To better model the intact kidney, we cultured human kidney organoids derived from induced pluripotent stem cells. We treated human kidney organoids grown using both three-dimensional and transwell protocols with CFH for 48 h. We found evidence for increased tubular toxicity, oxidative stress, mitochondrial fragmentation, endothelial cell injury and injury-associated transcripts compared to those of the untreated control group. To evaluate the protective effect of clinically available small molecules, we co-treated CFH-injured organoids with ascorbate (vitamin C) or acetaminophen for 48 h. We found significantly decreased toxicity, preservation of endothelial cells and reduced mitochondrial fragmentation in the group receiving ascorbate following CFH treatment. This study provides direct evidence that ascorbate or ascorbic acid protects human kidney cells from CFH-induced damage such as that in sepsis-associated acute kidney injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37232, USA.
- Vanderbilt Experimental Research Training Inclusion Community Engagement Skills (VERTICES) program, Vanderbilt University, Nashville, TN 37232, USA.
- Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
- Department of Cell Biology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
ORCID-Profile: Julie Bejoy, Justin M Farry, Eddie S Qian, Lorraine B Ware, Julie A Bastarache, Lauren E Woodard
Förderung
- NIGMS NIH HHS
- NEI NIH HHS
- NIEHS NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
- NIH HHS
- NCRR NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Bejoy, J., Farry, J. M., Qian, E. S., Dearing, C. H., Ware, L. B., Bastarache, J. A., & Woodard, L. E. (2023). Ascorbate protects human kidney organoids from damage induced by cell-free hemoglobin. Disease Models & Mechanisms, 16(12). https://doi.org/10.1242/dmm.050342
Vancouver
Bejoy J, Farry JM, Qian ES, Dearing CH, Ware LB, Bastarache JA, et al. Ascorbate protects human kidney organoids from damage induced by cell-free hemoglobin. Disease Models & Mechanisms. 2023;16(12). doi:10.1242/dmm.050342
BibTeX
@article{Bejoy2023,
author = {Bejoy, Julie and Farry, Justin M and Qian, Eddie S and Dearing, Curtis H and Ware, Lorraine B and Bastarache, Julie A and Woodard, Lauren E},
title = {Ascorbate protects human kidney organoids from damage induced by cell-free hemoglobin},
journal = {Disease Models & Mechanisms},
year = {2023},
volume = {16},
number = {12},
doi = {10.1242/dmm.050342}
}
EUVIMED